| 1 |
Post-market quality assessment of 22 ciprofloxacin brands by HPLC available in Bangladesh market |
|
|
| Md Hasanuzzaman Shohag, Syed Abdul Kuddus, Esfat M. Saim Brishty, Salman Sakir Chowdhury, Md Tofazzal Hossain, Maruf Hasan, Sabrin Islam Khan, Murad Hossain, Hasan Mahmud Reza |
|
| Heliyon. 2023; : e17180 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Assessment of quality of essential medicines in public health care facilities of Nepal: Findings of nationwide study |
|
|
| Neelam Dhakal, Pradip Gyanwali, Baburam Humagain, Rajendra BC, Nisha Jha, Phoolgen Sah, Amita Pradhan, Meghnath Dhimal, Anjani Kumar Jha, Nafis Faizi |
|
| PLOS Global Public Health. 2023; 3(5): e0001841 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Forecasting the Incremental Value to Society Created by a Class of New Prescription Drugs: A Proposed Methodology and Its Application to Treating Chronic Hepatitis C in India |
|
|
| V. Srinivasan, David E. Bloom, Alex Khoury |
|
| Applied Health Economics and Health Policy. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Availability, affordability, and quality of essential anti-seizure medication in Cambodia |
|
|
| Noudy Sengxeu, Chanraksmey Aon, Hanh Dufat, Farid Boumediene, Samleng Chan, Sina Ros, Pierre-Marie Preux, Voa Ratsimbazafy, Jeremy Jost |
|
| Epilepsia Open. 2021; 6(3): 548 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Analysis of Aspirin, Prasugrel and Clopidogrel in Counterfeit Pharmaceutical and Herbal Products: Plackett–Burman Screening and Box–Behnken Optimization |
|
|
| Mohammad Abdul-Azim Mohammad, Ehab Farouk Elkady, Marwa Ahmed Fouad, Wadhah Atef Salem |
|
| Journal of Chromatographic Science. 2021; 59(8): 730 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
DoE Screening and Optimization of Liquid Chromatographic Determination of Nicotinic Acid and Six Statins: Application to Pharmaceutical Preparations and Counterfeit Detection |
|
|
| Wadhah Atef Salem, Ehab Farouk Elkady, Marwa Ahmed Fouad, Mohammad Abdul-Azim Mohammad |
|
| Journal of Chromatographic Science. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Development and validation of a UPLC method for screening potentially counterfeit anti-hypertensive drugs using design of experiment |
|
|
| Chiguru Vishnuvardhan,R. Srinivas,N. Satheeshkumar |
|
| Analytical Methods. 2014; 6(13): 4610 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
The need for better data about counterfeit drugs in developing countries: a proposed standard research methodology tested in Chennai, India : Counterfeit drugs in developing countries |
|
|
| M. Seear, D. Gandhi, R. Carr, A. Dayal, D. Raghavan, N. Sharma |
|
| Journal of Clinical Pharmacy and Therapeutics. 2010; : no |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 9 |
Prevalence of counterfeit anthelminthic medicines: a cross-sectional survey in Cambodia |
|
|
| Mohiuddin Hussain Khan, Junko Okumura, Tey Sovannarith, Nam Nivanna, Manabu Akazawa, Kazuko Kimura |
|
| Tropical Medicine & International Health. 2010; 15(5): 639-644 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Regulatory status of banned drugs in India |
|
|
| Shaji, J., Lodha, S. |
|
| Indian Journal of Pharmaceutical Education and Research. 2010; 44(1): 86-94 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: A single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers |
|
|
| Muzaffar Iqbal, Arshad Khuroo, Lakhvinder S. Batolar, Monika Tandon, Tausif Monif, P.L. Sharma |
|
| Clinical Therapeutics. 2010; 32(3): 588 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 12 |
Travelling to India for the Delhi XIX Commonwealth Games 2010 |
|
|
| Marc T.M. Shaw, Peter A. Leggat, Santanu Chatterjee |
|
| Travel Medicine and Infectious Disease. 2010; 8(3): 129 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 13 |
Post-market in vitro bioequivalence study of six brands of ciprofloxacin tablets/caplets in Jos, Nigeria |
|
|
| Ngwuluka, N.C., Lawal, K., Olorunfemi, P.O., Ochekpe, N.A. |
|
| Scientific Research and Essays. 2009; 4(4): 298-305 |
|
| [Pubmed] [Google Scholar] |
|
| 14 |
Counterfeit and substandard drugs: The need for an effective and stringent regulatory control in India and other developing countries [1] |
|
|
| Sukhlecha, A. |
|
| Indian Journal of Pharmacology. 2007; 39(5): 255 |
|
| [Pubmed] [Google Scholar] |
|
